Ingrid Mayer

Role
Vice-president, Global Clinical Strategy Head, Breast Cancer at Astrazeneca at AstraZeneca
Location
Nashville, TN, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Ingrid Mayer

As a Vice-President, Global Clinical Development and Strategy Head in Late Oncology, I…

Experience

  1. Vice-president, Global Clinical Strategy Head, Breast Cancer at Astrazeneca

    AstraZeneca

    Dec 2021 — Present

    Leads AstraZeneca’s late stage Breast Cancer Oncology Portfolio of innovative medicines through global clinical development and submissions, pipeline strategy and external partnering activities. Experienced in working in a matrix environment, including significant interaction with internal representatives from regulatory, commercial, translational sciences, early and late development and external key opinion leaders from research and clinical communities. Late Development Oncology Drug Development Activities Astrazeneca, Gaithersburg, MD (from 2021 – present): • Define the overall strategic vision for Breast Cancer across AZ. • Shape the clinical development program across Global Product Teams, Early Development, Business Development • Bring clinical perspective on the commercial narrative and programs across Global Business Teams, Global Management Teams, franchises and functions • Define pipeline needs for the following years alongside Early Oncology, Translational Medicine and BD • Close interaction with the Global Product Teams, prioritizing of new opportunities and above asset activities through working groups and functions across ORD and OBU to support the strategic vision, and facilitating governance interactions Oversight, mentorship, advice and support a team of about 50 Clinical colleagues across global locations at Astrazeneca, Gaithersburg, MD (from 2021 – present): • Accurate assessment if proposed Ph3 trials are consistent with the overall disease strategy/ unmet needs • Ensure delivery/ accountability for the clinical execution of proposed Ph3 trials with close interactions with medical and clinical operation teams • Support interface with senior management regarding protocol approvals, clinical development plans, data contextualization, etc • Support internal and external key communications about a trial/ product • Identify and provide development opportunities for team members

Education

  • University of Illinois at Chicago

    Fellow, Hematology/ Oncology

  • Vanderbilt University School of Medicine

    Master of Science - MS, Clinical Investigation

  • Federal University of Sao Paulo

    Doctor of Medicine - MD, Medicine

  • University of Illinois at Chicago

    Internal Medicine and Hematology/Oncology, Internal Medicine Residency Program

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ingrid Mayer — Vice-president, Global Clinical Strategy Head, Breast Cancer at Astrazeneca at AstraZeneca in Nashville, TN, US | Unifers